Corey E - Search Results

1

Targeted therapy for advanced prostate cancer: inhibition of the PI3K/Akt/mTOR pathway.

Morgan TM, Koreckij TD, Corey E. Morgan TM, et al. Among authors: corey e. Curr Cancer Drug Targets. 2009 Mar;9(2):237-49. doi: 10.2174/156800909787580999. Curr Cancer Drug Targets. 2009. PMID: 19275762 Free PMC article. Review.

2

Elevation of cytokine levels in cachectic patients with prostate carcinoma.

Pfitzenmaier J, Vessella R, Higano CS, Noteboom JL, Wallace D Jr, Corey E. Pfitzenmaier J, et al. Among authors: corey e. Cancer. 2003 Mar 1;97(5):1211-6. doi: 10.1002/cncr.11178. Cancer. 2003. PMID: 12599227 Free article.

3

Metastases of prostate cancer express estrogen receptor-beta.

Lai JS, Brown LG, True LD, Hawley SJ, Etzioni RB, Higano CS, Ho SM, Vessella RL, Corey E. Lai JS, et al. Among authors: corey e. Urology. 2004 Oct;64(4):814-20. doi: 10.1016/j.urology.2004.05.036. Urology. 2004. PMID: 15491740

4

When prostate cancer meets bone: control by wnts.

Emami KH, Corey E. Emami KH, et al. Among authors: corey e. Cancer Lett. 2007 Aug 18;253(2):170-9. doi: 10.1016/j.canlet.2006.12.040. Epub 2007 Apr 25. Cancer Lett. 2007. PMID: 17462819 Review.

5

RAD001 (Everolimus) inhibits growth of prostate cancer in the bone and the inhibitory effects are increased by combination with docetaxel and zoledronic acid.

Morgan TM, Pitts TE, Gross TS, Poliachik SL, Vessella RL, Corey E. Morgan TM, et al. Among authors: corey e. Prostate. 2008 Jun 1;68(8):861-71. doi: 10.1002/pros.20752. Prostate. 2008. PMID: 18361409 Free PMC article.

6

Nemo-like kinase induces apoptosis and inhibits androgen receptor signaling in prostate cancer cells.

Emami KH, Brown LG, Pitts TE, Sun X, Vessella RL, Corey E. Emami KH, et al. Among authors: corey e. Prostate. 2009 Oct 1;69(14):1481-92. doi: 10.1002/pros.20998. Prostate. 2009. PMID: 19514049 Free PMC article.

7

Dasatinib inhibits the growth of prostate cancer in bone and provides additional protection from osteolysis.

Koreckij T, Nguyen H, Brown LG, Yu EY, Vessella RL, Corey E. Koreckij T, et al. Among authors: corey e. Br J Cancer. 2009 Jul 21;101(2):263-8. doi: 10.1038/sj.bjc.6605178. Br J Cancer. 2009. PMID: 19603032 Free PMC article.

8

HE3235 inhibits growth of castration-resistant prostate cancer.

Koreckij TD, Trauger RJ, Montgomery RB, Pitts TE, Coleman I, Nguyen H, Reading CL, Nelson PS, Vessella RL, Corey E. Koreckij TD, et al. Among authors: corey e. Neoplasia. 2009 Nov;11(11):1216-25. doi: 10.1593/neo.09960. Neoplasia. 2009. PMID: 19881957 Free PMC article.

9

Low dose, alternating electric current inhibits growth of prostate cancer.

Koreckij TD, Hill C, Azure L, Nguyen H, Kunz LL, Azure A, Corey E, Lange P, Vessella RL. Koreckij TD, et al. Among authors: corey e. Prostate. 2010 Apr 1;70(5):529-39. doi: 10.1002/pros.21087. Prostate. 2010. PMID: 19938042

10

Inhibition of angiopoietin-2 in LuCaP 23.1 prostate cancer tumors decreases tumor growth and viability.

Morrissey C, Dowell A, Koreckij TD, Nguyen H, Lakely B, Fanslow WC, True LD, Corey E, Vessella RL. Morrissey C, et al. Among authors: corey e. Prostate. 2010 Dec 1;70(16):1799-808. doi: 10.1002/pros.21216. Prostate. 2010. PMID: 20583134 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

640 results

Search Page